Company Updates
Crowd Mobile Achieves Record Half Year Results with Revenue Up 53%
Crowd Mobile Limited (ASX:CM8) has just reported record first half results for the six months to 31 December, 2016.
Actinogen Medical Makes Significant Progress with FDA and MHRA Approval After HY Results
Actinogen Medical (ASX: ACW) is pleased to provide a summary of the company’s progression over the half year ended 31 December 2016.
LatAm Auto Financial Results 2016; Market Share Continues to Grow in Mexico
LatAm Autos Limited (ASX: LAA) is pleased to release its financial statements and Appendix 4E for the year ended 31 December 2016.
SUDA Announces Strong Revenue Growth for January 2017
SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, announces today that it is wholly owned subsidiary Westcoast Surgical & Medical Supplies reported strong revenue growth in January 2017.
Owning “Pieces of Property” Becomes Increasingly Popular Due to DomaCom
A new idea of property investing in Australia is expanding into money-making areas, including offshore. Fractional investing, which allows people to buy slices of real estate.
Dr Martin Cross Appointed Non-Executive Director at Oncosil
OncoSil Medical Limited (ASX: OSL) is pleased to announce the appointment of Mr Lawrence Gozlan as an independent Non-executive Director of the Company, effective from today.
Thinxtra to Take On Telstra with its IoT Network as They Kick Off a $20m Capital Raise
Start-up Thinxtra has raised $20 million aimed at extending the reach of the company’s network, which will rival with business giant Telstra.
Imugene Receives Acceptance for Leading Clinical Drug
Imugene Limited (ASX:IMU) a clinical stage immuno-oncology company has been developing a leading clinical drug called HER-Vaxx for treatment of gastric cancer patients.
US Residential Fund Patriot’s Pointe Celebrates Completion of Purchase at US 22m
USR is delighted to declare the completion of the acquisition of a majority share of the grade A, Patriot’s Pointe multifamily apartment complex located in Hillsborough, North Carolina.
Backed By Leading Investment Groups and Family Offices
